178 related articles for article (PubMed ID: 36242992)
1. Discovery of a novel highly potent and low-toxic jatrophane derivative enhancing the P-glycoprotein-mediated doxorubicin sensitivity of MCF-7/ADR cells.
Maimaitijiang A; Wang B; Yang H; Tang D; Liu Y; Aisa HA
Eur J Med Chem; 2022 Dec; 244():114822. PubMed ID: 36242992
[TBL] [Abstract][Full Text] [Related]
2. Jatrophane diterpenoids from Euphorbia sororia as potent modulators against P-glycoprotein-based multidrug resistance.
Hu R; Gao J; Rozimamat R; Aisa HA
Eur J Med Chem; 2018 Feb; 146():157-170. PubMed ID: 29407947
[TBL] [Abstract][Full Text] [Related]
3. Jatrophane diterpenoids as multidrug resistance modulators from Euphorbia sororia.
Yang H; Mamatjan A; Tang D; Aisa HA
Bioorg Chem; 2021 Jul; 112():104989. PubMed ID: 34022709
[TBL] [Abstract][Full Text] [Related]
4. Diterpenoids from Euphorbia glomerulans with potential reversal activities against P-glycoprotein-mediated multidrug resistance.
Hasan A; Tang D; Nijat D; Yang H; Aisa HA
Bioorg Chem; 2021 Dec; 117():105442. PubMed ID: 34742027
[TBL] [Abstract][Full Text] [Related]
5. Design, Synthesis, and Biological Evaluation of Marine Lissodendrins B Analogues as Modulators of ABCB1-Mediated Multidrug Resistance.
Wang C; Zhang J; Wei X; Yang M; Ma W; Yu R; Liu M; Jiang T
Mar Drugs; 2023 May; 21(5):. PubMed ID: 37233508
[TBL] [Abstract][Full Text] [Related]
6. Dasatinib reverses the multidrug resistance of breast cancer MCF-7 cells to doxorubicin by downregulating P-gp expression via inhibiting the activation of ERK signaling pathway.
Chen T; Wang C; Liu Q; Meng Q; Sun H; Huo X; Sun P; Peng J; Liu Z; Yang X; Liu K
Cancer Biol Ther; 2015; 16(1):106-14. PubMed ID: 25482933
[TBL] [Abstract][Full Text] [Related]
7. Discovery of 2,5-disubstituted furan derivatives featuring a benzamide motif for overcoming P-glycoprotein mediated multidrug resistance in MCF-7/ADR cell.
Yang Z; Cai Y; Mao S; Wu Q; Zhu M; Cao X; Wei B; Tian JM; Bao X; Ye X; Chen J; Wang S; Yu Y; Zhang H; Sun X; Cui ZN; Li YS; Wang H
Eur J Med Chem; 2023 Sep; 257():115462. PubMed ID: 37229830
[TBL] [Abstract][Full Text] [Related]
8. Survivin transcription is associated with P-glycoprotein/MDR1 overexpression in the multidrug resistance of MCF-7 breast cancer cells.
Liu F; Liu S; He S; Xie Z; Zu X; Jiang Y
Oncol Rep; 2010 May; 23(5):1469-75. PubMed ID: 20372866
[TBL] [Abstract][Full Text] [Related]
9. Glabridin resensitizes p-glycoprotein-overexpressing multidrug-resistant cancer cells to conventional chemotherapeutic agents.
Qian J; Xia M; Liu W; Li L; Yang J; Mei Y; Meng Q; Xie Y
Eur J Pharmacol; 2019 Jun; 852():231-243. PubMed ID: 30959046
[TBL] [Abstract][Full Text] [Related]
10. Essential oils from Inula japonica and Angelicae dahuricae enhance sensitivity of MCF-7/ADR breast cancer cells to doxorubicin via multiple mechanisms.
Wu M; Li T; Chen L; Peng S; Liao W; Bai R; Zhao X; Yang H; Wu C; Zeng H; Liu Y
J Ethnopharmacol; 2016 Mar; 180():18-27. PubMed ID: 26795076
[TBL] [Abstract][Full Text] [Related]
11. Reversing Multidrug Resistance in Chemo-resistant Human Lung Adenocarcinoma (A549/DOX) Cells by Algerian Propolis Through Direct Inhibiting the P-gp Efflux-pump, G0/G1 Cell Cycle Arrest and Apoptosis Induction.
Kebsa W; Lahouel M; Rouibah H; Zihlif M; Ahram M; Abu-Irmaileh B; Mustafa E; Al-Ameer HJ; Al Shhab M
Anticancer Agents Med Chem; 2018; 18(9):1330-1337. PubMed ID: 30088453
[TBL] [Abstract][Full Text] [Related]
12. Novel virosecurinine bivalent mimetics as potent reversal agents against P-glycoprotein-mediated multidrug resistance.
Hou W; Meng Y; Xu XF; Huang ZX; Liu J; Wang ZY; Lin J; Chen WM
Eur J Med Chem; 2019 Dec; 183():111726. PubMed ID: 31585275
[TBL] [Abstract][Full Text] [Related]
13. The carotenoid fucoxanthin can sensitize multidrug resistant cancer cells to doxorubicin via induction of apoptosis, inhibition of multidrug resistance proteins and metabolic enzymes.
Eid SY; Althubiti MA; Abdallah ME; Wink M; El-Readi MZ
Phytomedicine; 2020 Oct; 77():153280. PubMed ID: 32712543
[TBL] [Abstract][Full Text] [Related]
14. Saracatinib (AZD0530) is a potent modulator of ABCB1-mediated multidrug resistance in vitro and in vivo.
Liu KJ; He JH; Su XD; Sim HM; Xie JD; Chen XG; Wang F; Liang YJ; Singh S; Sodani K; Talele TT; Ambudkar SV; Chen ZS; Wu HY; Fu LW
Int J Cancer; 2013 Jan; 132(1):224-35. PubMed ID: 22623106
[TBL] [Abstract][Full Text] [Related]
15. Bipiperidinyl derivatives of 23-hydroxybetulinic acid reverse resistance of HepG2/ADM and MCF-7/ADR cells.
Zhang DM; Li YJ; Shu C; Ruan ZX; Chen WM; Yiu A; Peng YH; Wang J; Lan P; Yao Z; Fung KP; Fu LW; Chen ZS; Ye WC
Anticancer Drugs; 2013 Jun; 24(5):441-54. PubMed ID: 23466650
[TBL] [Abstract][Full Text] [Related]
16. ZD6474 reverses multidrug resistance by directly inhibiting the function of P-glycoprotein.
Mi Y; Lou L
Br J Cancer; 2007 Oct; 97(7):934-40. PubMed ID: 17912240
[TBL] [Abstract][Full Text] [Related]
17. Synergistic effects of A-B-C-type amphiphilic copolymer on reversal of drug resistance in MCF-7/ADR breast carcinoma.
Zhang L; Lu J; Qiu L
Int J Nanomedicine; 2016; 11():5205-5220. PubMed ID: 27785023
[TBL] [Abstract][Full Text] [Related]
18. In silico comparisons between natural inhibitors of ABCB1/P-glycoprotein to overcome doxorubicin-resistance in the NCI/ADR-RES cell line.
Morsy MA; El-Sheikh AAK; Ibrahim ARN; Khedr MA; Al-Taher AY
Eur J Pharm Sci; 2018 Jan; 112():87-94. PubMed ID: 29133241
[TBL] [Abstract][Full Text] [Related]
19. Multifunctional PLGA Nanobubbles as Theranostic Agents: Combining Doxorubicin and P-gp siRNA Co-Delivery Into Human Breast Cancer Cells and Ultrasound Cellular Imaging.
Yang H; Deng L; Li T; Shen X; Yan J; Zuo L; Wu C; Liu Y
J Biomed Nanotechnol; 2015 Dec; 11(12):2124-36. PubMed ID: 26510307
[TBL] [Abstract][Full Text] [Related]
20. Reversal effect of FW-04-806, a macrolide dilactone compound, on multidrug resistance mediated by ABCB1 and ABCG2 in vitro and in vivo.
Zhang Z; Ma C; Li P; Wu M; Ye S; Fu L; Xu J
Cell Commun Signal; 2019 Sep; 17(1):110. PubMed ID: 31472682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
